The Board
Experienced senior executive and chair in the healthcare sector with roles at Merck, Reckitt & Colman, Aesica Pharmaceuticals and others
Alan Raymond
Chair
Gastrointestinal physiologist and biomedical scientist by training, co-founder of Aelius, MBA
Dr Peter Chater
CEO
Professor of Molecular Physiology with expertise in gatrointestinal physiology, mucus, pepsin and gastroeosophageal reflux
Professor Jeff Pearson
CSO
DMPK scientist and entrepreneur, Richard founded XenoGesis in 2011. Following a successful exit he joined Aelius as a Director
Dr Richard Weaver
Non-executive Director
Human physiologist and Biotechnologist, co-founder of Aelius Biotech with expertise in human trial design and gut modelling
Dr Matthew Wilcox
COO
Experienced senior financial director
Geoff Maclaughlan
CFO